Send us a text

This final segment with Jeff McIntyre of the Global Liver Institute (GLI) explores the panelists’ final thoughts around optimisms and worries for the Fatty Liver field going forward. Next week, the Surfersinvite you to join a live session covering the ICER draft pricing recommendations on resmetirom and obeticholic acid (OCA).

This exclusive opportunity for the Surfing NASH community to attend the live recording as audience members will take place on Monday, March 13th at 1700h CET, 1600h. In doing so, you will be able to voice questions and feedback on the pressing topic of imminent NASH drug approvals. To reserve a spot, please visit the following link: https://bit.ly/Surf-Live-With-Us.

To learn more about this opportunity, follow us on LinkedIn and subscribe to the newsletter. Alternatively, you can write to us directly at [email protected].

We look forward to surfing together soon!